Adherus AutoSpray ET Dural Sealant

FDA Premarket Approval P130014 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Alternate transport packaging to allow the single unit sale of the adherus autospray et dural sealant

DeviceAdherus AutoSpray ET Dural Sealant
Generic NameSealant, Dural
ApplicantHYPERBRANCH MEDICAL TECHNOLOGY, INC.
Date Received2020-04-13
Decision Date2020-07-10
PMAP130014
SupplementS007
Product CodeNQR 
Advisory CommitteeNeurology
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address HYPERBRANCH MEDICAL TECHNOLOGY, INC. 800-12 Capitola Drive durham, NC 27713

Supplemental Filings

Supplement NumberDateSupplement Type
P130014Original Filing
S007 2020-04-13 Real-time Process
S006 2019-08-16 30-day Notice
S005 2018-02-12 Normal 180 Day Track No User Fee
S004 2017-05-03 30-day Notice
S003
S002 2016-02-02 Normal 180 Day Track
S001

NIH GUDID Devices

Device IDPMASupp
00897146002018 P130014 000
30897146002026 P130014 002

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.